Terms ending in 2037
Every in-force patent on Purdue Pharma L.P.'s record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,372,713 | Chemical Formula Extrapolation and Query Building to Identify Source Documents Referencing Relevant Chemical Formula Moieties In force · High confidence | Accencio LLC | In force | High confidence | |
| US 10,550,090 | Process for Preparing Substituted 9,10-Dioxo-9,10-Dihydroanthrecenes and 6H-Anthra[1,9-cd]isoxazol-6-ones In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 10,858,326 | Oxazoline Pseudodimers, Pharmaceutical Compositions and the Use Thereof In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 10,974,081 | Treatment and Prevention of Sleep Disorders In force · High confidence | Knoa Pharma LLC | In force | High confidence | |
| US 11,738,023 | Treatment and Prevention of Sleep Disorders In force · High confidence | Knoa Pharma LLC | In force | High confidence | |
| US 12,370,191 | Treatment and Prevention of Sleep Disorders In force · High confidence | Knoa Pharma LLC | In force | High confidence | |
| US 10,745,402 | Morphinan Derivatives and Use Thereof In force · High confidence | Purdue Pharma L.P. | In force | High confidence |
7 of 7 patents shown. Soonest term end first, then patent number.
6 of these are in force and held by Purdue Pharma L.P..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.